Andrew Xiuxuan Zhu
Massachusetts General Hospital
Affiliation Massachusetts General Hospital Top Publications Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma (2020) – 7,611 citations Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases (2018) – 4,694 citations AASLD guidelines for the treatment of hepatocellular carcinoma (2017) – 4,213 citations Pembrolizumab in ... <a title="Andrew Xiuxuan Zhu" class="read-more" href="https://journalsworld.com/researchers/andrew-xiuxuan-zhu/" aria-label="Read more about Andrew Xiuxuan Zhu">Read more</a>
Read biography ↓Biography, research & contributions
Affiliation
Massachusetts General Hospital
Top Publications
- Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma (2020) - 7,611 citations
- Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases (2018) - 4,694 citations
- AASLD guidelines for the treatment of hepatocellular carcinoma (2017) - 4,213 citations
- Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial (2018) - 2,556 citations
- Hepatobiliary Cancers (2009) - 2,274 citations
At a glance
- Full name
- Andrew Xiuxuan Zhu
- ORCID
- 0000-0003-4873-5033
- OpenAlex ID
- https://openalex.org/A5088566246
Research interests
- Hepatocellular Carcinoma Treatment and Prognosis, Colorectal Cancer Treatments and Studies, Cholangiocarcinoma and Gallbladder Cancer Studies, Cancer Immunotherapy and Biomarkers, Pediatric Hepatobiliary Diseases and Treatments
Research topics
Education
Not yet documented in this profile.
Selected research & further reading
A curated reading list, not a ranking by citation count. References use DOI metadata, matching public scholarly records or authoritative lecture sources.
See the source-linked reading and original works in the research guide above.
Citation & publication trends
Annual counts are not yet available from a verified author record. Explore the research guide above for the work itself; publication and citation totals depend on database coverage.
Source: OpenAlex · Retrieved 2026-10-07. Metrics are database-specific and are not a scientific ranking.
Most-cited linked publications
Publications matched across ORCID and OpenAlex. Citation counts are source-specific.
- Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma ↗2020 · New England Journal of Medicine7,611OpenAlex citations
- 4,694OpenAlex citations
- AASLD guidelines for the treatment of hepatocellular carcinoma ↗2017 · Hepatology4,213OpenAlex citations
- 2,556OpenAlex citations
- Hepatobiliary Cancers ↗2009 · Journal of the National Comprehensive Cancer Network2,274OpenAlex citations
Recent linked publications
Publications matched across ORCID and OpenAlex. Citation counts are source-specific.
- Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma ↗2020 · New England Journal of Medicine
- AASLD guidelines for the treatment of hepatocellular carcinoma ↗2017 · Hepatology
- Hepatobiliary Cancers ↗2009 · Journal of the National Comprehensive Cancer Network
Journals published in
No verified record links added yet.
Related publishers
No verified record links added yet.
Institutions
Current verified institution
No verified record links added yet.
Previous institutions
No verified record links added yet.
Awards & honors
Not yet documented in this profile.
Career timeline
Not yet documented in this profile.
Co-authors
No verified record links added yet.
Education & career institution links
No verified record links added yet.
Claim & manage this profile
Are you this researcher? Sign in, provide identity evidence, and request administrator approval. Editing becomes available only after approval.
Sign in to claim this profileSources & data information
Editorial review: 2026-10-07 · Last data update: 2026-10-07 21:17:30
Unknown values are left blank. Linked publications may be a subset of total works. Identity verification, data retrieval and profile ownership are separate checks.